Corbus Pharmaceuticals (NASDAQ:CRBP) Stock, Earnings Estimates, EPS, And Revenue

Corbus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 7
EPS
$-1.150
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Corbus Pharmaceuticals using advanced sorting and filters.

Data brought to you by Benzinga APIs

Corbus Pharmaceuticals (CRBP) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-07$-1.15$-0.95-21.1 %
Jun 20242024-08-06$-0.90$-1.2628.6 %
Mar 20242024-05-07$-0.83$-1.5245.4 %
Dec 20232024-03-12$-1.81$-2.3623.3 %

Corbus Pharmaceuticals (CRBP) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20222022-08-09$0$100.00K-100.0 %
Mar 20222022-05-10$0$150.00K-100.0 %
Dec 20212022-03-08$0$350.00K-100.0 %
Sep 20212021-11-12$97.32K$650.00K-85.0 %

FAQ

Q

When is Corbus Pharmaceuticals (NASDAQ:CRBP) reporting earnings?

A

Corbus Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Corbus Pharmaceuticals (NASDAQ:CRBP)?

A

Corbus Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-1.15, which missed the estimate of $-0.95.

Q

What were Corbus Pharmaceuticals’s (NASDAQ:CRBP) revenues?

A

Corbus Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch